The Recall Desk
HighFDA (Drugs)·D-618-2015·Announced 2015-04-29

Attix Pharmaceuticals Recalls Demecarium Bromide Due to Penicillin Cross-Contamination Risk

Attix Pharmaceuticals is recalling Demecarium Bromide active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall involves a high-risk allergen (penicillin) cross-contamination hazard where no illnesses or injuries have been reported, fitting the criteria for a High severity score.

Plain-English summary

Attix Pharmaceuticals is recalling all lots of Demecarium Bromide active pharmaceutical ingredient. The product was packaged in varying grams or kilograms in bags or drums. The recall covers all lots repackaged and distributed between January 5, 2012, and February 12, 2015.

The recall was initiated because the product was repackaged in a facility that also handled penicillin products. The facility lacked adequate separation between the products, creating a potential for cross-contamination with penicillin. This contamination could pose a risk to individuals with penicillin allergies.

The product was distributed nationwide to compounding pharmacies and research organizations. The source text does not specify the total number of units affected or report any illnesses or injuries. Consumers and healthcare providers should stop using the affected product and contact their supplier or the recalling firm for further instructions.

The recalled product

Product
Demecarium Bromide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 470 recalled by Attix Pharmaceuticals under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 470 products in this recall →